Impact of concomitant DMARD therapy on adherence to treatment with etanercept and infliximab in rheumatoid arthritis. Results from a six-year observational study in southern Sweden
-
* Corresponding author: Lars E Kristensen LarsErik.Kristensen@skane.se
Arthritis Research & Therapy 2006, 8:R174 doi:10.1186/ar2084
Accesses
- Last 30 days: 45 accesses
- Last year: 630 accesses
- All time: 5343 accesses
Cited by
BioMed Central: 1 citation
|
Virginia Pascual-Ramos, Irazú Contreras-Yáñez, Antonio R Villa, Javier Cabiedes, Marina Rull-Gabayet Arthritis Research & Therapy 2009, 11:R26 (19 February 2009) Younger early rheumatoid arthritis patients are more persistent with medication than their older counterparts, meaning they reach sustained remission more quickly and benefit from reduced disease activity and disability levels.
|